Evidence indicates that GATA-3 is more sensitive than the previously mentioned markers mammaglobin and gross cystic disease fluid protein 15 (GCDFP-15) and is expressed in triple-negative breast cancer (13). The gene discussed is GATA3; the disease is triple-negative breast carcinoma.